CDK5 and prostate carcinoma: Overexpression of USF2 was linked to rheumatoid arthritis that is refractory to treatment through upregulation of proinflammatory cytokines [30], while stabilization of USF2 protein by CDK5-dependent phosphorylation promotes prostate cancer proliferation [36].